EverSource Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

EverSource Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.1K	Sell	204 -165	-45%	-$48.6K	﹤0.01%	1682
2026 Q1	$110K	Buy	369 +52	+16%	+$16.8K	﹤0.01%	1377
2025 Q4	$96.3K	Buy	317 +7	+2%	+$2.29K	﹤0.01%	1332
2025 Q3	$106K	Buy	310 +30	+11%	+$9.11K	﹤0.01%	1254
2025 Q2	$67.8K	Buy	280 +257	+1,117%	+$63K	﹤0.01%	1425
2025 Q1	$6.26K	Buy	23 +2	+10%	+$468	﹤0.01%	2388
2024 Q4	$3.88K	Sell	21 -9	-30%	-$1.84K	﹤0.01%	2453
2024 Q3	$6.74K	Buy	30 +13	+76%	+$2.34K	﹤0.01%	2086
2024 Q2	$2.83K	Buy	17 +4	+31%	+$616	﹤0.01%	2432
2024 Q1	$2K	Sell	13 -4	-24%	-$644	﹤0.01%	2383
2023 Q4	$3.07K	Sell	17 -18	-51%	-$3.26K	﹤0.01%	2045
2023 Q3	$6.3K	Hold	35	–	–	﹤0.01%	1604
2023 Q2	$6.24K	Sell	35 -2	-5%	-$461	﹤0.01%	1635
2023 Q1	$7.97K	Buy	37 +5	+16%	+$1.2K	﹤0.01%	1464
2022 Q4	$7.04K	Buy	32 +11	+52%	+$2.02K	﹤0.01%	1466
2022 Q3	$3K	Buy	21 +4	+24%	+$687	﹤0.01%	1603
2022 Q2	$3K	Sell	17 -25	-60%	-$3.9K	﹤0.01%	1451
2022 Q1	$8K	Buy	42 +8	+24%	+$1.7K	﹤0.01%	1110
2021 Q4	$9K	Buy	+34	New	+$11.5K	﹤0.01%	1025

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EverSource Wealth Advisors's ONC Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its BeOne Medicines Ltd (ONC) stake by 45% in Q2 2026, selling an estimated $48.6K and leaving 204 shares worth $58.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

EverSource Wealth Advisors first reported a position in ONC in Q4 2021 and has held it in 19 quarters since. The position peaked at $110K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

EverSource Wealth Advisors held 204 shares of BeOne Medicines Ltd worth $58.1K as of Q2 2026.
EverSource Wealth Advisors sold 165 BeOne Medicines Ltd shares in Q2 2026, an estimated $48.6K.
BeOne Medicines Ltd made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1682 holding.
EverSource Wealth Advisors first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 19 quarters since.
EverSource Wealth Advisors's BeOne Medicines Ltd position peaked at $110K in Q1 2026.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.